A mutant recombinant human endostatin containing the RGDRGD sequence suppresses tumor growth in a mouse xenograft model: Int J Clin Exp Pathol. 2017; 10(6): 6727-6734
International Journal of Clinical and Experimental Pathology · 2024
DOI: 10.62347/afyj3936 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Pathology, 2024. Verfasst von Minghua Ren.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ren, M. (2024). A mutant recombinant human endostatin containing the RGDRGD sequence suppresses tumor growth in a mouse xenograft model: Int J Clin Exp Pathol. 2017; 10(6): 6727-6734. International Journal of Clinical and Experimental Pathology. https://doi.org/10.62347/afyj3936
Vancouver
Ren M. A mutant recombinant human endostatin containing the RGDRGD sequence suppresses tumor growth in a mouse xenograft model: Int J Clin Exp Pathol. 2017; 10(6): 6727-6734. International Journal of Clinical and Experimental Pathology. 2024. doi:10.62347/afyj3936
BibTeX
@article{Ren2024,
author = {Ren, Minghua},
title = {A mutant recombinant human endostatin containing the RGDRGD sequence suppresses tumor growth in a mouse xenograft model: Int J Clin Exp Pathol. 2017; 10(6): 6727-6734},
journal = {International Journal of Clinical and Experimental Pathology},
year = {2024},
doi = {10.62347/afyj3936}
}
EUVIMED